CHRS Deferred Revenue

Coherus Oncology Inc · Deferred Revenue

CHRS logo

CHRS Deferred Revenue

Latest reported$0.00
CHRS FY Deferred Revenue ($2.03M → $0.00)
High-resolution chart · PNG

CHRS deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
8,817,000
1,962,000
50,951,000
23,992,000
14,283,000
2,025,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.